Showing results (71-80 of 635) with videos related to
Sort By:
Pageof 64
Psychological Medicine|February 1, 1980
The pathophysiology of extrapyramidal side-effects of neuroleptic drugsC D Marsden, P JennerInternational Journal of Clinical Pharmacology and Biopharmacy|July 1, 1975
Metabolic N-oxidation products of aliphatic amines as potential mediators in amine pharmacologyJ W Gorrod, P JennerNeuropharmacology|July 1, 1987
Chronic pharmacological manipulation of dopamine receptors in brainP Jenner, C D MarsdenNeuroscience Letters|January 4, 2001
Proteasomal function is impaired in substantia nigra in Parkinson's diseaseK S McNaught, P JennerBiochemical Pharmacology|September 7, 2000
Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activationK S McNaught, P JennerActa Psychiatrica Belgica|September 1, 1987
Neuroleptic-induced tardive dyskinesiaP Jenner, C D MarsdenJournal of Neural Transmission. Supplementum|January 1, 1986
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's diseaseP Jenner, C D MarsdenAnnals of Neurology|September 28, 1998
Understanding cell death in Parkinson's diseaseP Jenner, C W OlanowPharmacology & Therapeutics|February 7, 2006
What has been learnt from study of dopamine receptors in Parkinson's disease?M J Hurley, P JennerNeurology|December 1, 1996
Oxidative stress and the pathogenesis of Parkinson's diseaseP Jenner, C W OlanowPageof 64